During the last three months, 11 analysts shared their evaluations of Crinetics Pharmaceuticals (NASDAQ:CRNX), revealing diverse outlooks from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 3 | 8 | 0 | 0 | 0 |
Last 30D | 0 | 1 | 0 | 0 | 0 |
1M Ago | 0 | 0 | 0 | 0 | 0 |
2M Ago | 1 | 2 | 0 | 0 | 0 |
3M Ago | 2 | 5 | 0 | 0 | 0 |
Analysts have set 12-month price targets for Crinetics Pharmaceuticals, revealing an average target of $68.64, a high estimate of $97.00, and a low estimate of $54.00. This upward trend is evident, with the current average reflecting a 7.86% increase from the previous average price target of $63.64.
Decoding Analyst Ratings: A Detailed Look
An in-depth analysis of recent analyst actions unveils...
ログインすると全部閲覧できます。
ログイン